DSIP 10mg

DSIP 10 mg is a high-purity lyophilized peptide research compound supplied exclusively for scientific investigation and controlled laboratory experimentation. For research use only — not for human or veterinary use.  

Product Overview

DSIP (Delta Sleep-Inducing Peptide) is a synthetic peptide research compound developed for advanced laboratory investigations involving peptide signalling, neuropeptide biology and intracellular molecular communication. Its defined molecular structure has attracted scientific interest within experimental peptide research, where investigators continue to explore neuropeptide-mediated signalling mechanisms and biochemical regulatory systems under carefully controlled laboratory conditions. This preparation contains 10 mg of lyophilized DSIP supplied in a sealed research vial. Independent analytical testing measured an assay content of 13.23 mg for this production batch. Chromatographic analysis confirmed 99.3 percent purity, while identity was independently evaluated through FTIR spectrum analysis, retention time confirmation and molecular ion mass identification. Microbiological testing reported 0 CFU/g for both total aerobic microbial count and total yeast and mold count, while bacterial endotoxin analysis returned a result of 0.225 EU/mg. Comprehensive elemental impurity screening additionally reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. With its defined molecular identity, independently verified analytical profile and comprehensive third-party testing, DSIP provides researchers with a well-characterised peptide material suitable for advanced peptide investigations and controlled in vitro laboratory studies.  

Peptide Overview

DSIP is a synthetic peptide research compound commonly utilised in laboratory investigations involving neuropeptide chemistry, molecular signalling and intracellular communication. The compound is commonly referred to as Delta Sleep-Inducing Peptide and has become an established subject within experimental neuropeptide and molecular biology research. Researchers employ DSIP in controlled experimental models designed to investigate peptide-mediated signalling pathways, molecular interactions and biochemical regulatory systems. Its defined molecular structure and reproducible analytical characteristics allow identity and quality parameters to be evaluated using complementary chromatographic, spectroscopic and mass spectrometric techniques. Today, DSIP continues to form part of the expanding field of experimental peptide science involving neuropeptide biology, molecular communication and biochemical signalling research.  

Historical Background and Scientific Context

Neuropeptides have long been investigated within molecular biology because of their role as signalling molecules within complex biological communication systems. DSIP emerged within this broader field of neuropeptide research and has subsequently been investigated as an experimental peptide compound in controlled laboratory models. Advances in peptide synthesis and analytical chemistry have significantly improved the ability to manufacture and independently characterise research peptides such as DSIP. Modern analytical technologies including ultra-high-performance liquid chromatography, FTIR identification and mass spectrometry allow researchers to evaluate peptide identity, assay content, purity and manufacturing consistency. These analytical techniques can be complemented by bacterial endotoxin testing, microbiological analysis and elemental impurity screening to provide comprehensive batch-specific analytical documentation.  

Mechanistic Focus in Research

Within controlled laboratory environments, DSIP is commonly investigated in relation to neuropeptide signalling, molecular interactions and intracellular communication systems. Research investigations frequently explore:

• Neuropeptide biology
• Peptide-mediated signalling pathways
• Intracellular molecular communication
• Cellular regulatory mechanisms
• Biochemical pathway analysis
• Molecular peptide interactions
• Comparative neuropeptide investigations
• Controlled in vitro peptide studies

These experimental models allow researchers to investigate peptide-related molecular mechanisms while maintaining carefully controlled laboratory conditions.  

Analytical Verification (COA)

Each batch of DSIP supplied by Grail Formula undergoes comprehensive independent third-party laboratory verification to confirm peptide identity, assay content, purity and microbiological quality. Analytical testing for this batch was performed by Liquilabs s.r.o. Czechia using chromatographic, spectrometric, microbiological and mass spectrometry techniques. Batch: GF-DSIP10-B243

• Product Content: 10 mg
• Assay Content: 13.23 mg
• Purity: 99.3 %
• Identification by FTIR Spectrum: 985
• Identification by Retention Time: 0.983
• Molecular Ion Mass Identification: 848 Da
• Bacterial Endotoxins: 0.225 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g

Independent peptide screening measured an assay content of 13.23 mg with a reported analytical uncertainty of ±0.07 mg. Purity analysis confirmed 99.3 percent purity with a reported analytical uncertainty of ±0.5 percent. Identity was evaluated through FTIR spectrum analysis with a reported result of 985 and retention time analysis with a result of 0.983. Mass spectrometry identified a molecular ion mass of 848 Da with a reported analytical uncertainty of ±1 Da, providing an additional independent identity parameter for the tested material. Bacterial endotoxin testing returned a result of 0.225 EU/mg, remaining within the laboratory’s stated acceptable range of 0–0.5 EU/mg. Microbiological testing reported 0 CFU/g for total aerobic microbial count and 0 CFU/g for total yeast and mold count. Independent elemental impurity analysis reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm. These analytical procedures provide independent confirmation of peptide identity, purity, traceability and important batch-specific laboratory quality parameters.  

Research Applications

Within controlled laboratory environments, DSIP may be utilised in experimental models designed to investigate neuropeptide biology, molecular signalling and biochemical regulatory mechanisms. Examples of research applications include:

• Neuropeptide biology investigations
• Peptide signalling research
• Intracellular signalling investigations
• Molecular pathway analysis
• Biochemical regulation studies
• Comparative peptide investigations
• Molecular interaction research
• Controlled in vitro peptide studies

These applications are intended exclusively for scientific and laboratory investigation.  

Grail Formula Quality

Every Grail Formula research compound is supported by comprehensive independent analytical verification and transparent batch-specific laboratory documentation. Each production batch undergoes extensive testing to verify:

• Peptide identity confirmation
• Assay content verification
• Purity assessment
• Molecular ion mass verification
• Retention time confirmation
• FTIR spectrum identification
• Endotoxin analysis
• Microbial contamination screening
• Elemental impurity screening
• Complete batch traceability

Independent laboratory testing helps provide researchers with reliable, reproducible and transparently documented research material suitable for advanced scientific investigation.  

When You Choose Grail Formula

When selecting Grail Formula, researchers receive independently verified research compounds supported by complete Certificates of Analysis and transparent batch-specific laboratory documentation. Our analytical verification programme includes assay determination, purity confirmation, FTIR spectrum identification, retention time verification, molecular ion mass identification, endotoxin screening, microbiological analysis and comprehensive elemental impurity testing. Every production batch is accompanied by a downloadable Certificate of Analysis issued by Liquilabs s.r.o. Czechia, providing complete traceability, independent verification and confidence in the analytical quality of every research compound supplied.  

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.3 % purity confirmed by COA
• Assay content verified at 13.23 mg
• Identification confirmed by FTIR spectrum and retention time analysis
• Molecular ion mass identified at 848 Da
• Bacterial endotoxin level of 0.225 EU/mg
• No detectable heavy metals or microbial contamination
• Research-grade peptide compound
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.